Empathy and the Educational Approach to Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants.
Journal
American journal of therapeutics
ISSN: 1536-3686
Titre abrégé: Am J Ther
Pays: United States
ID NLM: 9441347
Informations de publication
Date de publication:
07 Aug 2020
07 Aug 2020
Historique:
entrez:
10
8
2021
pubmed:
11
8
2021
medline:
30
9
2021
Statut:
epublish
Résumé
Direct Oral Anticoagulants (DOACs) have shown to be at least effective and safer than anti-vitamin K (VKA) for the prophylaxis of cardioembolism during AF. These drugs do not need laboratory monitoring such as the VKA anticoagulants, but they are at risk of poor adherence and persistence as all drugs taken by mouth. Against this drawback, empathy may have an important role because it is important as a tool to be used for effective interpersonal communication. Patients like to be heard and understand that those who listen to them are immersed in their world. Empathy is part, and is a founding principle, of Narrative Medicine which today is a real discipline with many advantages because it is intrinsically therapeutic for the patient (in telling and being heard). Empathy prevents the disconnection that can intervene between the doctor and the patients. Have we ever wondered if we are sufficiently empathetic? Is it possible to measure our empathy? Yes, across Jefferson's scale. A high score on Jefferson's scale could certainly further improve the quality of the management of anticoagulated patients.
Identifiants
pubmed: 34375048
doi: 10.1097/MJT.0000000000001145
pii: 00045391-202106000-00009
doi:
Substances chimiques
Anticoagulants
0
Vitamin K
12001-79-5
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e355-e357Informations de copyright
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to declare.
Références
Fawzy AM, Yang WY, Lip GY. Safety of direct oral anticoagulants in real-world clinical practice: translating the trials to everyday clinical management. Expert Opin Drug Saf. 2019;18:187–209.
Abdou JK, Auyeung V, Patel JP, et al. Adherence to long-term anticoagulation treatment, what is known and what the future might hold. Br J Haematol. 2016;174:30–42.
World Health Organization. Adherence to long-term therapies: evidence for action: World Health Organization; 2003:1–110. Available at: http://www.who.int/chp/knowledge/publications/adher-ence_report/en/. ISBN 92 4 154599 2.
Banerjee S. Multimorbidity-older adults need health care that can count past one. Lancet. 2014;385:587–589.
Lip GY, Kamath S, Jafri M, et al. Ethnic differences in patient perceptions of atrial fibrillation and anticoagulation therapy: the West Birmingham Atrial Fibrillation Project. Stroke. 2002;33:238–242.
Elwyn G, Frosch DL, Kobrin S. Implementing shared decision-making: consider all the consequences. Implement Sci. 2016;11:114.
Barcellona D, Fenu L, Marongiu F. Point-of-care testing INR: an overview. Clin Chem Lab Med. 2017;55:800–805.
Prisco D, Ageno W, Becattini C, et al. Italian intersociety consensus on DOAC use in internal medicine. Intern Emerg Med. 2017;12:387–406.
Marongiu F, Barcellona D. Direct oral anticoagulants: what can we learn? Intern Emerg Med. 2018;13:989–992.
Chan KE, Robert P, Giugliano RP, et al. Non vitamin K anticoagulant agents in patients with advanced chronic kidney disease or on dialysis with AF. J Am Coll Cardiol. 2016;67:2888–2899.
Hojat M, Gonnella JS, Nasca TJ, et al. Physician empathy: definition, components, measurement, and relationship to gender and specialty. Am J Psychiatry. 2002;159:1563–1569.
Barcellona D, Contu P, Marongiu F. A “two-step” educational approach for patients taking oral anticoagulants does not improve therapy control. J Thromb Thrombolysis. 2006;22:185–190.
Barcellona D, Contu P, Marongiu F. Patient education and oral anticoagulant therapy. Haematologica. 2002;87:1081–1086.
Charon R. The patient-physician relationship. Narrative medicine: a model for empathy, reflection, profession, and trust. JAMA. 2001;286:1897–1902.
Zaharias G. What is narrative-based medicine? Narrative-based medicine 1. Can Fam Physician. 2018;64:176–180.
Hojat M, Gonnella JS, Nasca TJ, et al. Comparisons of American, Israeli, Italian and Mexican physicians and nurses on the total and factor scores of the Jefferson scale of attitudes toward physician-nurse collaborative relationships. Int J Nurs Stud. 2003;40:427–435.
Hojat M, Louis DZ, Markham FW, et al. Physicians' empathy and clinical outcomes for diabetic patients. Acad Med. 2011;86:359–364.
Marongiu F, Barcellona D. The future of anticoagulation clinics: a journey to thrombosis centers? Haematologica. 2005;90:298–301.
Mohammad I, Korkis B, Garwood CL. Incorporating comprehensive management of direct oral anticoagulants into anticoagulation Clinics. Pharmacotherapy. 2017;37:1284–1297.